Players in the pharma&healthcare hospital sectors achieve truly significant turnover. Invenium Legaltech supports several large operating companies on a global scale, working alongside the CFO to consolidate the company’s strategies for controlling and reducing DSO, i.e., Days Sales Outstanding – the average time it takes to collect payments.
We believe it is essential, however, to interact and operate alongside new and young companies, which have the primary objective of focusing on their core business and growth, while implementing solid credit control strategies.
This is the case of Altais Pharma: an Italian company engaged in the marketing of specialized and niche products, related – in particular – to rare diseases: these are the so-called “orphan drugs” (if you want to know more about the subject: see Italian Medicines Agency).
For Altais Pharma, the Invenium Legaltech Team carries out monitoring, reminders, verification and accounting alignment, and dispute resolution. Invenium Legaltech has always advocated for wide-ranging support that takes the form of a wide-ranging credit management service, especially in the pharma&healthcare sector.
In the competitive pharma&healthcare world, financial management is crucial for business success. In the pharmaceutical industry, the issue of late or non-payment is even more important than in other sectors. These issues are relevant to all entities, and insurance companies, for example.
For the CEO and CFO of mother companies and investee companies, sound credit control strategies are an essential element of good operational management, even in one of the most crucial sectors of the global economic system.
For more information on credit collection services, please contact info@invenium-legaltech.it or visit our website.
